Medical devices, healthcare technology and the business of care
PMA approval · P960009

MEDTRONIC ACTIVA TREMOR CONTROL SYSTEM

Medtronic, Inc. · Decision date Jul 31, 1997

MEDTECHLEDGER EXPLANATIONP960009

What did the FDA approve?

The FDA approved Medtronic's Activa Tremor Control System on July 31, 1997, under PMA P960009. The approval covers the Model 3387 DBS lead, Model 7495 extension, Model 7424 implantable pulse generator, Model 7458 memory module, Model 7432 console programmer, bur hole ring and cap, Model 7452 magnet, Model 3625 test stimulator, and Model 3353/3354 lead frame kits and accessories.

The dated approval statement describes the device as indicated for unilateral thalamic stimulation to suppress upper extremity tremor in patients diagnosed with essential tremor or parkinsonian tremor not adequately controlled by medications, where the tremor constitutes a significant functional disability. The statement reports an intended use; it does not independently establish safety or clinical effectiveness.

FDA approval order statement

APPROVAL FOR THE MEDTRONIC(R) ACTIVA(TM) TREMOR CONTROL SYSTEM WHICH INCLUDES THE MODEL 3387 DBS(TM) LEAD, MODEL 7495 EXTENSION, MODEL 7424 IMPLANTABLE PULSE GENERATOR (IPG), MODEL 7458 MEMORY MODULE, MODEL 7432 CONSOLE PROGRAMMER, BUR HOLE RING AND CAP, MODEL 7452 MAGNET, MODEL 3625 TEST STIMULATOR (SCREENER) AND MODEL 3353/3354 LEAD FRAME KITS AND ACCESSORIES. THIS DEVIC IS INDICATED FOR UNILATERAL THALAMIC STIMULATION FOR THE SUPPRESSION OF TREMOR IN THE UPPER EXTREMITY IN PATIENTS WHO ARE DIAGNOSED WITH ESSENTIAL TREMOR OR PARKINSONIAN TREMOR NOT ADEQUATELY CONTROLLED BY MEDICATIONS AND WHERE THE TREMOR CONSTITUTES A SIGNIFICANT FUNCTIONAL DISABILITY.
Regulatory pathway
Original PMA
Clinical specialty
Neurology
Decision date
Jul 31, 1997

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P960009
Regulatory pathway
Premarket approval application
Product code
MHY
Decision code
APPR
Decision date
Jul 31, 1997
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Stimulator, electrical, implanted, for parkinsonian tremor.

Product code
MHY
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P960009 received

    Application receipt date recorded by FDA.

  2. P960009 · FDA decision

    APPR

  3. P960009/S546 · Related supplement

    MEDTRONIC ACTIVA TREMOR CONTROL SYSTEM

  4. P960009/S542 · Related supplement

    Activa Deep Brain Stimulation Therapy System, Percept PC BrainSense

  5. P960009/S547 · Related supplement

    Activa Deep Brain Stimulation Therapy System, Percept PC BrainSense (DBS Neurostimulator Implantable B35200)

  6. P960009/S548 · Related supplement

    Activa Deep Brain Stimulation Therapy System, Percept PC BrainSense

  7. P960009/S545 · Related supplement

    Activa Deep Brain Stimulation Therapy System, Percept PC BrainSense (B32000)

Timeline entries are records held by MedtechLedger for P960009. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P960009

Explore the linked device profile

Other records with product code MHY

Product / regulatory recordCompanyPathwayDecision dateSource
ABBOTT MEDICALPMA supplementOct 30, 2026FDA
ABBOTT MEDICALPMA supplementOct 30, 2026FDA
ABBOTT MEDICALPMA supplementOct 28, 2026FDA
ABBOTT MEDICALPMA supplementOct 27, 2026FDA
Infinity DBS IPGP140009/S139
ABBOTT MEDICALPMA supplementSep 23, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic, Inc.

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
7000 Central Ave., NE, Minneapolis, MN, 55432

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records